I spent weeks testing red light therapy devices to see if they improved wrinkles. I also spoke to dermatologists on the science behind the masks.
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
A team of scientists at the University of Maryland (UMD) is gathering first-of-its-kind data through a device you put on your underwear.
SAN FRANCISCO -- Adding hormone therapy to postoperative radiotherapy did not improve overall survival (OS) for most men with prostate cancer, according to a meta-analysis of individual patient data.
In this observational study, researchers aimed to assess real-world use of relugolix among prostate cancer patients. Clinical Advisor, a trusted source of medical news and feature content for ...
Precision medicine treatment options in metastatic prostate cancer are expanding rapidly—and while it allows care to be tailored to each patient’s individual needs, it also poses increasingly complex ...
Cleveland Clinic recently became the first health system in the U.S. to use a new robotic-assisted surgery system for prostatectomy. The FDA approved the Hugo RAS system in December. The system ...
Krista McCay is a writer specializing in video game guides and walkthroughs. She first entered the industry in 2022 while studying English at UC Santa Barbara and working part-time as an editor. It ...
RICHMOND, Va. (January 20, 2026) – Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently awarded a $1.8 million, 3-year grant from the ...
NHS England has given the green light for abiraterone to be used to treat men with prostate cancer that has not metastasised. It is the first time the drug will be available for these patients in ...
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results